Altimmune, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Altimmune, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Altimmune, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $100K, unchanged year-over-year.
  • Altimmune, Inc. annual Operating Lease, Payments for 2023 was $500K, unchanged from 2022.
  • Altimmune, Inc. annual Operating Lease, Payments for 2022 was $500K, unchanged from 2021.
  • Altimmune, Inc. annual Operating Lease, Payments for 2021 was $500K, a 25% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $500K $0 0% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $500K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $500K +$100K +25% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $400K +$19.2K +5.04% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $381K Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.